Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Biomagnetic Technologies

This article was originally published in The Gray Sheet

Executive Summary

Biomagnetic Technologies: Magnetic source imaging device company plans restructuring due to "lower short term market projections for its products," the company says. As part of the restructuring, Scott Buchanan will assume the position of president and chief operating officer, replacing James Schumacher who will remain chairman and CEO. Buchanan was previously VP-engineering and applications. An initial staff reduction of 16 employees is expected to be followed by a layoff of 28 more workers after development of the Magnes 2500 WH magnetic source imaging system is completed. Biogmagnetic Technologies also plans on reducing non-personnel related program costs...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007336

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel